Skip to main content

Advances in Acute Myeloid Leukemia (AML)

March 8, 2022

We invite you to learn more about:

  • Treatment advances for acute myeloid leukemia (AML)
  • Precision medicine for AML
  • The importance of clinical trials for AML
  • Side-effect management

Uma Borate, MD, MS
Associate Professor
Ohio State University
The James Comprehensive Cancer Center
Columbus, OH

Program Support

Support for this program is provided by Bristol-Myers Squibb; and Genentech, Inc. & Biogen.

See All Resources

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.